1. Home
  2. EVH vs SPRY Comparison

EVH vs SPRY Comparison

Compare EVH & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVH
  • SPRY
  • Stock Information
  • Founded
  • EVH 2011
  • SPRY 2015
  • Country
  • EVH United States
  • SPRY United States
  • Employees
  • EVH N/A
  • SPRY N/A
  • Industry
  • EVH Other Consumer Services
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVH Consumer Discretionary
  • SPRY Health Care
  • Exchange
  • EVH Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • EVH 1.2B
  • SPRY 1.2B
  • IPO Year
  • EVH 2015
  • SPRY N/A
  • Fundamental
  • Price
  • EVH $9.02
  • SPRY $14.45
  • Analyst Decision
  • EVH Strong Buy
  • SPRY Strong Buy
  • Analyst Count
  • EVH 14
  • SPRY 4
  • Target Price
  • EVH $16.64
  • SPRY $28.75
  • AVG Volume (30 Days)
  • EVH 2.4M
  • SPRY 1.9M
  • Earning Date
  • EVH 05-08-2025
  • SPRY 05-08-2025
  • Dividend Yield
  • EVH N/A
  • SPRY N/A
  • EPS Growth
  • EVH N/A
  • SPRY N/A
  • EPS
  • EVH N/A
  • SPRY 0.08
  • Revenue
  • EVH $2,554,741,000.00
  • SPRY $89,149,000.00
  • Revenue This Year
  • EVH N/A
  • SPRY $1.49
  • Revenue Next Year
  • EVH $16.02
  • SPRY $141.68
  • P/E Ratio
  • EVH N/A
  • SPRY $180.50
  • Revenue Growth
  • EVH 30.09
  • SPRY 297063.34
  • 52 Week Low
  • EVH $8.35
  • SPRY $7.55
  • 52 Week High
  • EVH $33.63
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • EVH 43.41
  • SPRY 58.07
  • Support Level
  • EVH $8.40
  • SPRY $13.77
  • Resistance Level
  • EVH $9.21
  • SPRY $15.12
  • Average True Range (ATR)
  • EVH 0.53
  • SPRY 1.08
  • MACD
  • EVH -0.09
  • SPRY 0.09
  • Stochastic Oscillator
  • EVH 33.79
  • SPRY 70.88

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: